NuCana plc has announced significant initial data from its Phase 1b/2 modular study of NUC-3373. The study showed encouraging results for patients with advanced solid tumors who had exhausted other treatment options, demonstrating significant tumor reductions and prolonged progression-free survival.
Company Information
Company
NuCana
Location
Edinburgh, Scotland, United Kingdom
About
NuCana is a clinical-stage biopharmaceutical company developing safer and more effective cancer treatments by applying its proprietary ProTide technology to transform widely used chemotherapy agents. With a pipeline that includes NUC-7738 and NUC-3373, NuCana aims to overcome the limitations of conventional nucleoside analogs and improve outcomes for patients with solid and hematological tumors.
Fundz sees it the moment NuCana ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
EdinburghBiotechnologyHealth CareMedicalTherapeuticsPharmaceutical